401
Participants
Start Date
February 28, 2006
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
limited lymphadenectomy
Field 5 (Group external iliac rigt) Field 7 (Group external iliac left) Field 9 (obturatorical Group right) Field 11 (obturatorical Group left) Field 13 (Group internal iliac right) Field 14 (Group internal iliac left)
extended lymphadenectomy
Field 1 (paracaval right) Field 2 (interaortocaval) Field 3 (paraaortal left) Field 4 (Group iliac artery right) Field 5 (Group external iliac rigt) Field 6 (Group iliac artery left) Field 7 (Group external iliac left) Field 8 (presacral) Field 9 (obturatorical Group right) Field 10 (deep obturatorical Group right) Field 11 (obturatorical Group left) Field 12 (deep obturatorical Group left) Field 13 (Group internal iliac right) Field 14 (Group internal iliac left)
Urological Hospital Kassel, Kassel
Department of urology, städt. Klinikum Fulda, Fulda
Otto von Guericke University, Magdeburg
Paracelsus Hospital, Düsseldorf
Helios Klinikum Wuppertal, Wuppertal
Urological hospital, Städt. Kliniken Dortmund, Dortmund
University of Essen, Essen
University of Cologne, Cologne
Hospital Holweide, Cologne
Saarland University, Homburg/Saar
Klinikum Ludwigshafen, Ludwigshafen
Eberhard Karls University, Tübingen
Städt. Klinikum, Karlsruhe
Klinikum r. d. Isar der TUM, München
Urological hospital, University Hospital Ulm, Ulm
Heinrich Heine University, Düsseldorf
Eli Lilly and Company
INDUSTRY
Association of Urologic Oncology (AUO)
OTHER